HIV treatment / promising new products / needed new technologies / HIV therapy / manufacturing processes / /
MedicalCondition
HIV / disease / HIV/AIDS / HIV opportunistic infection / /
Organization
The Medicines Patent Pool / World Health Organization / European Medicines Agency / United Nations / US Food and Drug Administration / Federal Trade Commission / /
Person
Bhavesh Shah / Arvind Vasudeva / Satyanarayana / A.K. Khanna / Greg Perry / Subhanu Saxena / Jinliang Li / /
Position
Executive Director / Chief Executive Officer / Global CEO / Vice President of Desano / Director of International Marketing / /
The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries MPP signs sub-licences with six generic manufacturers for the development of Phase III drug Tenofovir Al